AIDS News and Research

RSS

Opiates themselves are superior to sedatives for treating infants born to women who used heroin or methadone while pregnant

Opiates appear to better "ameliorate the withdrawal, facilitate feeding and potentially reduce the likelihood of seizures," according to two new systematic reviews done by David Osborn, a neonatologist at the Royal Prince Alfred Hospital in Sydney, Australia, and colleagues.

26 Jul 2005

Analysis of the Phase I/II clinical trial of HIV drug candidate PA-457

V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.

26 Jul 2005

Variation in HIV's ability to disable host defenses contributes to rapid evolution

One of the reasons HIV is so difficult to contain and treat is its rapid evolution. Understanding how host defenses and viral countermeasures contribute to that evolution is vital.

25 Jul 2005

Pneumonia - another use for statins

Patients hospitalised because of pneumonia are at less risk of dying from the disease if they have been taking the widely used cholesterol-lowering drugs 'statins' before hospital admission.

25 Jul 2005

Nonsmokers report better health and fewer symptoms of depression than smokers

People who have successfully quit smoking cigarettes are more likely to have visited a trusted health care provider and to report good mental health than current smokers, according to a recent study.

25 Jul 2005

Discovery of a receptor that appears to function as one "lock" that HSV opens to allow it to enter human cells

It's one of the most common viruses in America, and one that causes the most guilt and shame. It can get inside almost any kind of human cell, reproduce in vast numbers, and linger for years in the body, causing everything from recurrent genital blisters to sores around the mouth. Its complications can kill, and it may increase susceptibility to many nerve and brain disorders.

24 Jul 2005

New research leads to better infant hearing aids

The University of Western Sydney's MARCS Auditory Laboratories is leading the way with groundbreaking research, exploring the auditory abilities of infants, so hearing aids can correctly amplify the frequencies that babies need to develop communication and language skills.

21 Jul 2005

New design for HIV vaccine trials in animals

Emory University researchers have proposed a new design for HIV vaccine trials in animals that would more closely mimic how humans are exposed to the virus - potentially giving AIDS researchers a more effective tool in developing successful treatments to prevent HIV infection.

20 Jul 2005

University of Florida researcher finds way to explore role of microRNAs in specific tissue

University of Florida researchers have learned how to selectively shut down a flyweight-sized genetic molecule that packs a heavyweight punch, a discovery that may help doctors better understand cancer, birth defects and other health problems.

20 Jul 2005

Moving towards a cheap and easy way to monitor HIV/AIDS

Doctors regularly monitor the level of an immune cell in the blood called a CD4 cell in HIV-infected individuals, to decide when to start treatment and when to change medications.

19 Jul 2005

Discrimination of people living with HIV/AIDS in Nigeria

People living with HIV/AIDS face many forms of stigma and discrimination. This is the case in whichever country they may live, as has been shown in a number of previous research studies.

19 Jul 2005

Activist groups hinder important clinical trials of HIV medication

One promising approach to help stem the global HIV epidemic is to give commercial sex workers an HIV medication (such as the drug tenofovir) before they have high risk sex in the hope of reducing their chances of becoming infected, an approach called "pre-exposure prophylaxis" (PREP).

19 Jul 2005

First generation of HIV vaccines may be available within 10 years but availability doesn't guarantee uptake

Public health officials must be sensitive to concerns about stigma and fear of vaccine-induced infection if they want women to take advantage of HIV vaccines now under development, says a University of Toronto researcher.

18 Jul 2005

Close connection between gender-based violence and HIV infection

amfAR has released an issue brief demonstrating a close connection between gender-based violence and HIV infection. The New York-based AIDS research foundation is calling for resources to develop, test, and implement behavioral, biomedical, and social interventions to address violence as both a cause and a consequence of HIV infection.

18 Jul 2005

Malpractice litigation has little to do with erratic quality of health care

Conventional wisdom holds that malpractice lawsuits are the bane of modern medicine, with high insurance premiums driving doctors from the profession and the threat of lawsuits discouraging health-care employees from reporting and correcting medical mistakes.

17 Jul 2005

Ranbaxy receives tentative FDA approval to manufacture and market Zidovudine tablets

India's Ranbaxy Laboratories has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets USP, 300 mg.

15 Jul 2005

Police shooting of AIDS protesters by South African police

AIDS Healthcare Foundation (AHF) today expressed its profound outrage over the unprovoked attack -- including what is believed to be the first-ever police shooting of AIDS protesters anywhere worldwide -- by South African police on AIDS activists conducting a peaceful protest.

15 Jul 2005